Characterization of a Murine Monoclonal Antibody to Cryptococcus neoformans Polysaccharide That Is a Candidate for Human Therapeutic Studies

Casadevall, Arturo, Cleare, Wendy, Feldmesser, Marta, Glatman-Freedman, Aharona, Goldman, David L., Kozel, Thomas R., Lendvai, Nikoletta, Mukherjee, Jean, Pirofski, Liise-anne, Rivera, Johanna, Rosas, Angel L., Scharff, Matthew D., Valadon, Philippe, Westin, Katherine, Zhong, Zhaojing·1998·Antimicrobial Agents and Chemotherapy
DOI 10.1128/aac.42.6.1437

Cited by (297)

Items 201–297 of 297

  1. The function of conserved amino acids in or near the complementarity determining regions for related antibodies to Cryptococcus neoformans glucuronoxylomannan
    Antonio S. Nakouzi · 2003 · Molecular Immunology
  2. DAP12 Inhibits Pulmonary Immune Responses to Cryptococcus neoformans
    Lena J. Heung, Tobias M. Hohl · 2016 · Infection and Immunity
  3. Cytokines and Costimulatory Molecules: Positive and Negative Regulation of the Immune Response to Cryptococcus Neoformans
    Anna Vecchiarelli · 2001 · Springer eBooks
  4. Monoclonal Antibodies against Cell Wall Chitooligomers as Accessory Tools for the Control of Cryptococcosis
    Alexandre Bezerra Conde Figueiredo, Fernanda L. Fonseca, Diogo Kuczera, Fernando de Paiva Conte, Marcia Arissawa, Marcio L. Rodrigues · 2021 · Antimicrobial Agents and Chemotherapy
  5. AICAR transformylase/IMP cyclohydrolase (ATIC) is essential for de novo purine biosynthesis and infection by Cryptococcus neoformans
    Maha S.I. Wizrah, Sheena M.H. Chua, Zhenyao Luo, Mohammad Kawsar Manik, Mengqi Pan, Jessica M.L. Whyte, Avril A. B. Robertson, Ulrike Kappler, Boštjan Kobe, James A. Fraser · 2022 · Journal of Biological Chemistry
  6. Targeting Glycans on Human Pathogens for Vaccine Design
    Stefanie A. Krumm, Katie J. Doores · 2018 · Current topics in microbiology and immunology
  7. Cryptococcus neoformans releases proteins during intracellular residence that affect the outcome of the fungal–macrophage interaction
    Eric H. Jung, Yoon‐Dong Park, Quigly Dragotakes, Lia Sanchez Ramirez, Daniel F. Q. Smith, Flavia C. G. Reis, Amanda Dziedzic, Márcio Lourenço Rodrigues, Rosanna P. Baker, Peter Richard Williamson et al. · 2022 · microLife
  8. Cryptococcosis and Cryptococcal Meningitis: A Narrative Review and the Up-to-Date Management Approach
    Zaheer Ahmad Qureshi, Haider Ghazanfar, Faryal Altaf, Ali Ghazanfar, Khushbu Z Hasan, Sameer Kandhi, Ked Fortuzi, Arundhati Dileep, Shitij Shrivastava · 2024 · Cureus
  9. CAR T Cell-Therapy for Infectious Diseases with Emphasis on Invasive Fungal Infections
    Thiago Aparecido da Silva · 2021 · Therapeutic Delivery
  10. Pathogenesis of Cryptococcus neoformans
    Erin E. McClelland, Arturo Casadevall, Helene C. Eisenman · 2007 · Springer eBooks
  11. A Novel, Inexpensive In-House Immunochromatographic Strip Test for Cryptococcosis Based on the Cryptococcal Glucuronoxylomannan Specific Monoclonal Antibody 18B7
    Pakornswit Sathongdejwisit, Kritsada Pruksaphon, Akarin Intaramat, Pisinee Aiumurai, Nitat Sookrung, Kavi Ratanabanangkoon, Joshua Daniel Nosanchuk, Sirida Youngchim · 2021 · Diagnostics
  12. Radioimmunotherapy with an antibody to the HPV16 E6 oncoprotein is effective in an experimental cervical tumor expressing low levels of E6
    Rébécca Phaëton, Matthew Harris, Zewei Jiang, Xing Guo Wang, Mark H. Einstein, Gary L. Goldberg, Arturo Casadevall, Ekaterina Dadachova · 2010 · Cancer Biology & Therapy
  13. GXMR-CAR containing distinct GXM-specific single-chain variable fragment (scFv) mediated the cell activation against Cryptococcus spp. And had difference in the strength of tonic signaling
    Michele Procópio Machado, Matheus Henrique dos Santos, Júlia Garcia Guimarães, Gabriela Yamazaki de Campos, Patrícia Kellen Martins Oliveira Brito, Camilly Melo Garcia Ferreira, Caroline Patini Rezende, Natália Frota, Sandro G. Soares, Pappanaicken R. Kumaresan et al. · 2023 · Bioengineered
  14. Comparative Evaluation of Capsular Polysaccharide-Specific IgM and IgG Antibodies and F(ab′)2 and Fab Fragments as Delivery Vehicles for Radioimmunotherapy of Fungal Infection
    Ekaterina Dadachova, Ruth A. Bryan, Xianchun Huang, Geraldina Ortiz, Tiffany Moadel, Arturo Casadevall · 2007 · Clinical Cancer Research
  15. A glucuronoxylomannan-like glycan produced by Trichosporon mucoides
    Ana Claudia G. Zimbres, Priscila Costa Albuquerque, Luna Sobrino Joffe, Taiane Nascimento de Souza, Leonardo Nimrichter, Stefânia de Oliveira Frazão, Patrícia Albuquerque, Fernanda L. Fonseca, Márcio Lourenço Rodrigues · 2018 · Fungal Genetics and Biology
  16. Remodeling of the Histoplasma Capsulatum Membrane Induced by Monoclonal Antibodies
    Meagan Burnet, Daniel Zamith‐Miranda, Heino Martin Heyman, Karl Weitz, Erin Bredeweg, Joshua Daniel Nosanchuk, Ernesto Satoshi Nakayasu · 2020 · Vaccines
  17. Anti-glucuronoxylomannan IgG1 specific antibodies production in Cryptococcus neoformans resistant mice.
    Claudia Marcela Parra‐Giraldo, John Mario González, Elizabeth Castañeda, Susana Fiorentino G · 2005 · PubMed
  18. Immunometabolic reprogramming in macrophages infected with active and dormant Cryptococcus neoformans : differential modulation of respiration, glycolysis, and fatty acid utilization
    Clara Luna Marina, Raffael Júnio Araújo de Castro, Paula Maria Quaglio Bellozi, Ana Miguel Cruz, Pedro Henrique Bürgel, Paul G. Weightman Potter, Craig Beall, Aldo Henrique Tavares, Andreza Fabro De Bem, Alexandre Alanio et al. · 2024 · Infection and Immunity
  19. Chimeric antigen receptor–based therapies beyond cancer
    María Velasco‐de Andrés, Guillermo Muñoz‐Sánchez, Laura Carrillo‐Serradell, María del Mar Gutiérrez‐Hernández, Cristina Català, Marcos Isamat, Francisco Lozano · 2023 · European Journal of Immunology
  20. Cryptococcosis mimicking lung carcinoma with brain metastases in an immunocompetent patient
    Samantha Ya Lyn Ang, Victor Weng Leong Ng, Shree Dinesh Kumar, Sharon Y. Y. Low · 2016 · Journal of Clinical Neuroscience
  21. Histoplasma capsulatum Glycans From Distinct Genotypes Share Structural and Serological Similarities to Cryptococcus neoformans Glucuronoxylomannan
    Diego de Souza Gonçalves, C. Noval, Marina da Silva Ferreira, Leandro Honorato, Glauber Ribeiro de Sousa Araújo, Susana Frasés, Cláudia Vera Pizzini, Joshua Daniel Nosanchuk, Radamés J. B. Cordero, Márcio Lourenço Rodrigues et al. · 2021 · Frontiers in Cellular and Infection Microbiology
  22. Cryptococcus neoformans infections: aspartyl protease potential to improve outcome in susceptible hosts
    Frédérique Vernel-Pauillac, Christine Laurent‐Winter, Laurence Fiette, Guilhem Janbon, Vishukumar Aimanianda, Françoise Dromer · 2024 · mBio
  23. The CNS
    Mark A. Rivieccio, Melissa Cosenza, Celia F. Brosnan, Qiusheng Si, Sun Hee Lee · 2005 · CRC Press eBooks
  24. Differences in Sirtuin Regulation in Response to Calorie Restriction in Cryptococcus neoformans
    Tejas Bouklas, Lindsey Masone, Bettina C. Fries · 2018 · Journal of Fungi
  25. The enigmatic role of fungal annexins: the case of Cryptococcus neoformans
    Maria Maryam, Man Shun Fu, Alexandre Alanio, Emma Camacho, Diego de Souza Gonçalves, Eden E Faneuff, Nina T. Grossman, Arturo Casadevall, Carolina Coelho · 2019 · Microbiology
  26. The buoyancy of cryptococcal cells and its implications for transport and persistence of Cryptococcus in aqueous environments
    Isabel Angelica Jimenez, Piotr R. Stempinski, Quigly Dragotakes, Seth D. Greengo, Lia Sanchez Ramirez, Arturo Casadevall · 2024 · mSphere
  27. Host Defense Against Cryptococcal Disease: Is There a Role for B Cells and Antibody-Mediated Immunity?
    Kausik Datta, Krishanthi S. Subramaniam · 2014 · Current Fungal Infection Reports
  28. A rare case of neonatal cryptococcal meningitis in an HIV-unexposed 2-day-old infant: the youngest to date?
    Dominic Anthony O’Reilly · 2015 · Paediatrics and International Child Health
  29. Evolutionary unique N-glycan-dependent protein quality control system plays pivotal roles in cellular fitness and extracellular vesicle transport in Cryptococcus neoformans
    Catia Mota, Kiseung Kim, Ye Ji Son, Eun Jung Thak, Su‐Bin Lee, Ju-El Kim, Jeong‐Kee Yoon, Min‐Ho Kang, Heeyoun Hwang, Yong‐Sun Bahn et al. · 2024 · eLife
  30. Diagnostic Performances of an in-House Immunochromatography Test Based on the Monoclonal Antibody 18B7 to Glucuronoxylomannan for Clinical Suspected Cryptococcosis: a Large-Scale Prototype Evaluation in Northern Thailand
    Kritsada Pruksaphon, Artid Amsri, Patcharin Thammasit, Joshua Daniel Nosanchuk, Pisinee Aiumurai, Sirida Youngchim · 2024 · Mycopathologia
  31. Reduced growth and biofilm formation at high temperatures contribute to Cryptococcus deneoformans dermatotropism
    Claudia Charles‐Niño, Gunjan M. Desai, Nicholas Koroneos, Mohamed F. Hamed, Neena Jain, William Lopes, Anthony Braswell, Alexander Linares, Melissa E. Munzen, Joshua Daniel Nosanchuk et al. · 2025 · Disease Models & Mechanisms
  32. Antimicrobial immunotherapeutics: past, present and future
    Derry K. Mercer, Marie-Louise R. Francis, Douglas J. Fraser-Pitt · 2021 · Emerging Topics in Life Sciences
  33. Immunity to Fungal Infections
    Simon Altmeier, Salomé LeibundGut‐Landmann · 2017 · Springer eBooks
  34. Fungal infections of the lung
    Anke V. Jacobs, Howard L. Leaf · 1999 · Current Infectious Disease Reports
  35. A point mutation in the Ch3 domain of human IgG3 inhibits antibody secretion without affecting antigen specificity
    Gary R. McLean, Marcela Torres, Brendon Trotter, Michela Noseda, S. Bryson, Emil F. PAI, John W. Schrader, Arturo Casadevall · 2005 · Molecular Immunology
  36. Biological Activity of a Mouse-Human Chimeric Immunoglobulin G2 Antibody toCryptococcus neoformansPolysaccharide
    Katherine Westin Kwon, Nikoletta K. Lendvai, Sherie Leaver Morrison, K. Ryan Trinh, Arturo Casadevall · 2002 · Clinical and Vaccine Immunology
  37. Host environmental conditions induce small fungal cell size and alter population heterogeneity in Cryptococcus neoformans
    Xin Zhou, Hanna Zafar, Poppy Sephton-Clark, Sally H. Mohamed, Ambre F. Chapuis, Maria Makarova, Donna M. MacCallum, Rebecca A. Drummond, Ivy M. Dambuza, Elizabeth Ripley Ballou · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Acquired Antibody-Mediated Immunity to Fungi
    Liise‐anne Pirofski, Arturo Casadevall · 2014 · ASM Press eBooks
  39. Will the Real Immunogens Please Stand Up: Exploiting the Immunogenic Potential of Cryptococcal Cell Antigens in Fungal Vaccine Development
    Samantha L. Avina, Siddhi Pawar, Amariliz Rivera, Chaoyang Xue · 2024 · Journal of Fungi
  40. Lack of Toll-Like Receptor 9 Exacerbates Ocular Impairment and Visual Loss During Systemic Cryptococcus gattii Infection
    Elias Barbosa da Silva-Júnior, Victor G. Araújo, Carlla Assis Araújo-Silva, Luciana Polaco Covre, Joyce Cristina Guimarães-de-Oliveira, Israel Diniz-Lima, Leonardo Freire‐de‐Lima, Alexandre Morrot, Lycia de Brito‐Gitirana, Jose Osvaldo Previato et al. · 2025 · The Journal of Infectious Diseases
  41. Cryptococcus neoformans capsule protects cell from oxygen reactive species generated by antimicrobial photodynamic inactivation
    Renato Araújo Prates, Michael Richard Hamblin, Ilka Tiemy Kato, Beth Burgwyn Fuchs, Eleytherios Mylonakis, Martha Simões Ribeiro, George P. Tegos · 2011 · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE
  42. Bionized Nanoferrite Particles Alter the Course of Experimental Cryptococcus neoformans Pneumonia
    Livia Cristina Liporagi Lopes, Preethi C. Korangath, Samuel Ribeiro dos Santos, Kathleen L. Gabrielson, Robert Ivkov, Arturo Casadevall · 2022 · Antimicrobial Agents and Chemotherapy
  43. Assessing the In Vitro Potential of Glatiramer Acetate (Copaxone®) as a Chemotherapeutic Candidate for the Treatment of Cryptococcus neoformans Infection
    Vinícius Alves, Pedro Martins, Bruna Porpino Miranda, Iara Bastos de Andrade, Luiza Pereira, Christina Takiya Maeda, Glauber Ribeiro de Sousa Araújo, Susana Frasés · 2023 · Journal of Fungi
  44. Molecular Pathogenesis of Fungal Infections
    Brahm H. Segal · 2007 · Humana Press eBooks
  45. Pulmonary Innate and Adaptive Defenses againstCryptococcus
    Kristi L. Williams, Floyd L. Wormley, Scarlett Geunes-Boyer, Jo Rae Wright, Gary B. Huffnagle · 2014 · ASM Press eBooks
  46. Adjuvant Pam3CSk4 does not improve the immunization against Cryptococcus gattii infection in C57BL/6 mice
    Gabriela Yamazaki de Campos, Patrícia Kellen Martins Oliveira Brito, Júlia Garcia Guimarães, Letícia Serafim da Costa, Javier Emílio Lazo Chica, Thiago Aparecido da Silva · 2023 · PeerJ
  47. Effect of Rapamycin on Cryptococcus Neoformans : Cellular Organization, Biophysics and Virulence Factors
    Iara Bastos de Andrade, Vinícius Alves, Luiza Pereira, Bruna Porpino Miranda, Dario Corrêa-Junior, Maria Helena Galdino Figueiredo‐Carvalho, Marcos Vinícius Ferreira dos Santos, Rodrigo Almeida‐Paes, Susana Frasés · 2023 · Future Microbiology
  48. Immunomodulators: Potential in Treatment of Systemic Fungal Infections
    Qamar Zia, Nishat Fatima, Maroof Alam, Deepa Bisht, Prashant Yadav, Iqbal Ahmad, Farrukh Aqil, Mohammad Owais · 2010 · Springer eBooks
  49. [Monoclonal antibodies recognizing the capsular polysaccharide of Cryptococcus neoformans].
    Hermis Rodríguez Sánchez, Maritza Pupo Antúnez, María Teresa Illnait Zaragozí, Anselmo J. Otero, Gerardo Martínez Machín · 2005 · PubMed
  50. Assessing Phagocytosis of Cryptococcus neoformans Cells in Human Monocytes or the J774 Murine Macrophage Cell Line
    Emmanuel Lafont, Aude Sturny-Leclère, Carolina Coelho, Fanny Lanternier, Alexandre Alanio · 2024 · Methods in molecular biology
  51. Host Immune Responses Against Pulmonary Fungal Pathogens
    Lasch Karen, Michal A. Olszewski, Floyd L. Wormley · 2012 · InTech eBooks
  52. Aspects of Isotype Selection
    Zehra Kaymakcalan, Alexander R. Ibraghimov, Andrew G. Goodearl, Jochen G. Salfeld · 2010 · Springer eBooks
  53. Complement and Its Role in Fungal Diseases
    Thomas R. Kozel · 2004 · Springer eBooks
  54. Pathogenicity ofCryptococcus neoformans: an Evolutionary Perspective
    Óscar Zaragoza, Susana Frasés, Arturo Casadevall · 2014 · ASM Press eBooks
  55. Immunotherapy for Fungal Infections
    Arturo Casadevall · 2002 · Humana Press eBooks
  56. Alternative Therapy Options for Pathogenic Yeasts: Targeting Virulence Factors with Non-conventional Antifungals
    Obinna Tobechukwu Ezeokoli, Ntombikayise Precious Nkomo, Onele M. N. Gcilitshana, Carolina Henritta Pohl · 2023 · Springer eBooks
  57. Host–Pathogen Interactions and Correlated Factors That Are Affected in Replicative-Aged Cryptococcus neoformans
    Vanessa K. A. Silva, Sungyun Min, Kyungyoon Yoo, Bettina C. Fries · 2024 · Journal of Fungi
  58. Exploring immunotherapy to control human infectious diseases
    Praveen Rai, Sanjana Mehrotra, Vijay Kumar Prajapati · 2024 · Advances in protein chemistry and structural biology
  59. Role of glucuronoxylomannan and steryl glucosides in protecting against cryptococcosis
    Gabriel Soares Matos, Samyr Machado Querobino, Verônica S. Brauer, Luna Sobrino Joffe, Nívea Pereira de Sá, Caroline Mota Fernandes, Deveney Dasilva, Vanessa A. da Silva, Marinaldo Pacífico Cavalcanti Neto, Tyler G. Normile et al. · 2025 · mBio
  60. Mannoprotein Cig1 contributes to the immunogenicity of a heat-killed F-box protein Fbp1 Cryptococcus neoformans vaccine model
    Samantha L. Avina, Siddhi Pawar, Roshni N. Kadam, Amariliz Rivera, Chaoyang Xue · 2025 · Infection and Immunity
  61. Cryptococcus: Spectrum of Disease and Treatment
    Tihana A. Bicanic, Thomas Stephen Harrison · 2009 · Springer eBooks
  62. Vaccines and Antibody Therapies fromCryptococcus neoformansto Melanoma
    Arturo Casadevall, Ekaterina Dadachova, Liise‐anne Pirofski · 2014 · ASM Press eBooks
  63. Fungal Vaccine Development
    J. Nosanchuk, G. Deepe · 2006 · ASM Press eBooks
  64. Immunology of infections with Cryptococcus neoformans
    Pauline M. Ellerbroek, Anna Vecchiarelli, Andy I. M. Hoepelman, Frank E. J. Coenjaerts · 2007 · Springer eBooks
  65. Inmunoterapia con agentes biológicos e infecciones fúngicas: riesgos y beneficios
    Tonny Williams Naranjo, Damaris Lopera, Luz Elena Cano · 2012 · Infectio
  66. In vitro models to analyse fungal infection
    Susanne Gola, David M. Arana, Rebeca Alonso‐Monge, Elvira Román, Jesús Plá · 2007 · Springer eBooks
  67. Metabolic plasticity and virulence of Cryptococcus neoformans are regulated by mitochondrial homeostasis
    José Alberto Patiño-Medina, Emma Camacho, Arturo Casadevall · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  68. Acquired Humoral Immunity toCryptococcus neoformans
    Liise‐anne Pirofski, Arturo Casadevall · 2014 · ASM Press eBooks
  69. Mecanismo de ação da microplusina, um peptídeo quelante de cobre com atividade antimicrobiana.
    Fernanda Dias da Silva · 2008
  70. Binding of glucuronoxylomannan to CD14 receptor in human A549 alveolar cells induces IL-8
    Fabiane M. Barbosa, Fernanda L. Fonseca, Rodrigo Tinoco Figueiredo, Marcelo Torres Bozza, Arturo Casadevall, Leonardo Nimrichter, Márcio Lourenço Rodrigues, Paulo de Góes · 2006
  71. Macrophage Autophagy in Immunity to Cryptococcus
    André Moraes Nicola, Patrícia Albuquerque, Luis R. Martinez, Rafael Antonio Dal-Rosso, Carolyn Saylor, Magdia De Jesus, Joshua Daniel Nosanchuk, Arturo Casadevall · 2012
  72. from Cryptococcus gattii correlate with polysaccharide diameter 2
    Fernanda L. Fonseca, Lilian Lie Nohara, Radamés J. B. Cordero, Susana Frasés, Igor Correia de Almeida, Leonardo Nimrichter, Márcio Lourenço Rodrigues · 2010
  73. Pathogen-Specific Adaptations to Conserved Signaling Pathways in Cryptococcus neoformans
    Kyla S. Ost · 2016 · DukeSpace (Duke University)
  74. Immunomodulators
    J. Andrew Alspaugh · 2009 · CRC Press eBooks
  75. Immunomodulators: What is the evidence for use in mycoses?
    J. Andrew Alspaugh · 2019 · CRC Press eBooks
  76. Effect of GXM (Glucuronoxylomannan) on the Inflammatory Response in Lung Infection Caused by Cryptococcus neoformans (Serotype A) in Immunodeficient Murine Model (BALB/c-SCID)
    Eriques Goncalves Silva, Sandra Marilia de Souza Silva, Claudete Rodrigues Paula, Luciana da Silva Ruiz · 2016 · Journal of Medical Microbiology & Diagnosis
  77. The mouse lung early cellular innate immune response is not sufficient to control fungal infection with Cryptococcus neoformans
    Jacob Rudman, Helen M. Marriott, Leo M. Carlin, Simon Andrew Johnston · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  78. Antibodies
    Jose Luis Lopez-Ribot, Rosalía Diez‐Orejas, Concha Gil · 2007 · Springer eBooks
  79. Faculty Opinions recommendation of FTY720 reactivates cryptococcal granulomas in mice through S1P receptor 3 on macrophages.
    Michail S. Lionakis · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  80. Faculty Opinions recommendation of FTY720 reactivates cryptococcal granulomas in mice through S1P receptor 3 on macrophages.
    June Kwon‐Chung · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  81. Commentary: Role of Sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development
    Luis R. Martinez · 2015 · Frontiers in Microbiology
  82. A rare case of neonatal cryptococcal meningitis in an HIV-unexposed 2-day-old infant: the youngest to date?
    Dominic Anthony O’Reilly · 2016 · Paediatrics and International Child Health
  83. Preparation of Biologically Active Fractions Enriched with Glucuronoxylomannan, the Main Antigen of the Cryptococcal Capsule
    Luísa J. Jozefowicz, Márcio Lourenço Rodrigues · 2024 · Methods in molecular biology
  84. Evolutionary unique N-glycan-dependent protein quality control system plays pivotal roles in cellular fitness and extracellular vesicle transport in Cryptococcus neoformans
    Catia Mota, Kiseung Kim, Ye Ji Son, Eun Jung Thak, Su‐Bin Lee, Ju-El Kim, Jeong‐Kee Yoon, Min‐Ho Kang, Heeyoun Hwang, Yong‐Sun Bahn et al. · 2025 · eLife
  85. Effects of human immunoglobulins on Cryptococcus neoformans morphology and proteome
    Taiane Nascimento de Souza, Haroldo César de Oliveira, Antonio S. Nakouzi, M.H.Silla Santos, Daniel Zamith‐Miranda, Joshua Daniel Nosanchuk, Márcio Lourenço Rodrigues, Liise‐anne Pirofski · 2026 · mBio
  86. Protéase de Cryptococcus neoformans : rôle au cours de l'infection et intérêt comme biomarqueur d'évaluation pronostique
    Frédérique Vernel-Pauillac · 2016 · theses.fr (ABES)
  87. A structure-guided pipeline yields peptide inhibitors that disarm fungal peptidase-driven virulence and resistance
    Davier Gutierrez‐Gongora, Jacob Hambly, Norris Chan, Oscar Romero, Michael Woods, Esther Olabisi-Adeniyi, Aimee Maria Dawe, María Juliana Mantilla, Gregory A. Wasney, Jared S. Deyarmin et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  88. Cryptococcus neoformans invasion of the orbital compartment and periocular spaces following intracerebral infection in mice
    Melissa E. Munzen, Vanessa Enriquez, Claudia Charles‐Niño, Marta Reguera-Gómez, Karina Alviña, Michael Robert Dores, Luis R. Martinez · 2026 · iScience
  89. Antifungal vaccine development: where we are, where we are headed
    Monika Janeczko, Konrad Kubiński, Leszek Wawiórka · 2026 · Vaccine
  90. Calcium triggers Cryptococcus neoformans aggregation by forming coordination bonds with capsular glucuronoxylomannan
    Gracen R. Gerbig, Arturo Casadevall, Sindhoora Raja, Jason Louis Sonnenberg, Maggie P. Wear · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  91. Combination therapy for fungal diseases: the role of immunotherapy in the present and the future
    Laura Seldeslachts, Simon Feys, Frank L. van de Veerdonk, Joost Wauters · 2026 · Current Opinion in Infectious Diseases
  92. Selection and Characterization of Novel Glucuronoxylomannan-Mimetic Peptides for Potential Diagnosis of Cryptococcosis
    Paulo Roberto Da Silva, Kássia Gonçalves de Castro, David Nascimento Silva Teixeira, Carlos Ueira‐Vieira, Luíz Ricardo Goulart, Alexandre de Paula Rogério, Jussara Gonçalves Vieira, Luciano Pereira Rodrigues · 2026 · International Journal of Peptide Research and Therapeutics
  93. Monoclonal Antibody-Based Anti-Cryptococcosis Therapy
    Marcos William de Lima Gualque, Gabriel Rezende Pimenta, Daniel Gomes de Sousa, Lara Yukari Ogasawara, Aline Ruan Wu, Mariana Macul, Matheus Torrichelli Antunes, Marcela Santana Demarchi, Giovana Moreno Fratus, Maria Júlia Siqueto et al. · 2026 · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
  94. Virulence factors of Cryptococcus neoformans and Cryptococcus gattii : two sides of the same coin
    Daniel Felipe Freitas de Jesus, Larissa Dunkl Brujas, Thayná Lopes Barreto, Letícia Serafim da Costa, Cristina de Castro Spadari, Kelly Ishida · 2026 · Future Microbiology
  95. The Cryptococcus neoformans titanide is a pathogenic cell type that arises from typical yeast cells in response to host conditions
    Abigail M Potton, Iana M. Kalinina, Gordon D. Brown, Maria Makarova, Sandra Catania, Dora Corzo-León, Elizabeth Ripley Ballou · 2026 · PLoS Biology
  96. Antifungal Trials: Progress, Approaches, New Targets, and Perspectives in Cryptococcosis
    Peter G. Pappas · 2014 · ASM Press eBooks
  97. Untitled work
    Duong · 2000 · 10.1002/1097-0169(200011)47:3